PRAN, Prana Biotechnology Ltd.

** PRAN reported that The Journal Of Neurochemistry has published an update on the mechanism of action of PBT2 in the treatment of Alzheimer's Disease (AD). The study explains how PBT2 is able to restore cognition in AD sufferers through repair of affected Alzheimer's brains.

The findings further explain the rapid improvement in cognition previously reported in transgenic Alzheimer's mice and in patients in a Phase IIa clinical trial with PBT2.

These new results further explain how PBT2 can achieve rapid improvements in cognition: by liberation of copper and zinc trapped in amyloid deposits and returning those essential metals to neurons, where they are needed for normal function.

PRAN has developed a proprietary library of class-leading chemical compounds. This library is combined with a drug development program to explore novel therapeutics in multiple disease indications. The scientific focus of PRAN is upon neurological diseases, particularly Alzheimer?s, Parkinson?s and Huntington?s diseases.

More about PRAN at www.pranabio.com

**********************

GR, Goodrich Corp.

** According to reports, United Technologies Corporation is exploring a takeover of GR.

GR is a leading global supplier of systems and services to the Aerospace and Defense industry.

More about GR at www.goodrich.com

**********************

KAZ, BMB Munai Inc.

** KAZ has completed the sale of all of its interests in Emir Oil LLP to a subsidiary of MIE Holdings Corporation.

KAZ is an independent oil and gas company engaged in the exploration, development and production of crude oil and natural gas.

More about KAZ at www.bmbmunai.com

**************************************************************

********************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOmega.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyomega.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.